Can hormone therapy cause joint pain, and how to cope

Yes, joint pain (arthralgia) can occur with several types of hormone therapy, and it is especially common with aromatase inhibitors used for breast cancer. ^[1] Joint and muscle pain are among the most frequent side effects reported with drugs like anastrozole, letrozole, and exemestane. ^[1] This musculoskeletal syndrome can include stiffness, “start-up” pains when moving after rest, carpal tunnel symptoms, and reduced grip strength. [PM13]

Which therapies are most linked to joint pain

• Aromatase inhibitors (AIs: anastrozole, letrozole, exemestane): These medicines lower estrogen in postmenopausal women and are strongly associated with joint and muscle pain. ^[1] In comparative data, anastrozole users had more joint disorders (arthritis, arthrosis, arthralgia) than tamoxifen users. ^[2] Musculoskeletal events were significantly more frequent with anastrozole than with tamoxifen in large trials. ^[3]

• Tamoxifen: Joint pain can occur but appears less common compared to aromatase inhibitors. [PM17] Tamoxifen carries different risks (for example, blood clots and endometrial cancer), but joint symptoms are generally less prominent than with AIs. ^[1]

• Goserelin plus exemestane (ovarian suppression + AI): Patient information notes muscle and joint pain and stiffness can happen. ^[4]

• Androgen deprivation therapy (ADT) in prostate cancer: Musculoskeletal complaints, including arthralgia and joint stiffness, are recognized in this setting; some regimens may show differing rates of these events. [PM18]

Why joint pain happens

Estrogen deprivation seems to play a key role. Lower estrogen levels can affect joints, tendons, and surrounding tissues, leading to stiffness, start-up pain, and tendon sheath changes that contribute to discomfort. [PM13] Postmenopausal status and low estrogen are associated with higher risk of developing joint symptoms during endocrine therapy. [PM17]

How common is it

Joint and muscle pain are among the most common side effects reported with aromatase inhibitors in routine care and clinical trials. ^[1] In head-to-head comparisons, musculoskeletal complaints were more frequent with anastrozole than with tamoxifen, highlighting the burden of AI-related arthralgia. ^[3] These symptoms can impact quality of life and sometimes lead to early discontinuation, which is linked to worse outcomes if therapy is stopped prematurely. ^[5]

Practical ways to cope

Talk to your care team early if you develop joint pain there are several strategies that can help while keeping cancer treatment on track. ^[6]

• Confirm safety of over‑the‑counter pain relievers: Non‑steroidal anti‑inflammatory drugs (NSAIDs) like ibuprofen or acetaminophen can reduce pain for many people, but it’s best to check for interactions and personal risks. ^[6]

• Heat, gentle movement, and stretching: Local heat packs and gentle range‑of‑motion exercises may ease stiffness, especially morning stiffness or “start‑up” pain after rest. ^[4]

• Physical activity program: Structured, arthritis‑style exercise programs adapted for AI users have been developed to reduce pain and improve function. ^[7] Such programs can support adherence to therapy by improving symptoms. ^[8]

• Consider medication adjustments: If pain is persistent, your clinician may adjust dosing schedules or consider switching within the endocrine therapy class (for example, to another AI or to tamoxifen when clinically appropriate). ^[6] Tamoxifen appears to have a lower incidence of joint symptoms than AIs in comparative analyses. [PM17]

• Address hand/wrist symptoms: Carpal tunnel–type complaints and reduced grip strength are part of the AI musculoskeletal syndrome and may benefit from wrist splints, ergonomic changes, and targeted therapy. [PM13]

• Bone and cardiovascular health monitoring: Because some endocrine therapies affect bone density and fracture risk, your team may monitor and treat bone health proactively (for example, with calcium/vitamin D, weight‑bearing exercise, or bone‑protective medications when indicated). ^[9]

• Stay adherent when possible: Early discontinuation of hormonal therapy is associated with increased mortality in breast cancer, so symptom control and support are important to help you stay on therapy. ^[5]

When to seek medical help urgently

Seek prompt help for new swelling, redness, severe pain, numbness, or weakness, or if pain significantly limits daily activities. ^[6] Also report signs of other serious side effects that sometimes accompany specific drugs (for example, blood clot symptoms with tamoxifen). ^[1]

Outlook

Most joint symptoms can be managed with a mix of lifestyle steps, simple medications, and sometimes treatment adjustments, allowing many people to continue effective hormone therapy. ^[6] With proactive monitoring and supportive care, quality of life often improves and adherence is more achievable. ^[5]

---

추가로 궁금한 내용은 퍼슬리에게 알려주세요.